search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
TECHNOLOGY AND INNOVATION


IRT in clinical trials: what to add to your shopping list


IRT software systems can make or break a clinical trial.  provider, writes Reynald Castañeda.


I


nteractive response technology (IRT) is at the heart of clinical trials: the software system is used to randomise patients and


manage the study supply chain. IRT should be used by default for any trial from the  enabled services vice president Craig Mooney  from an IRT to track patients, he adds. Trial sponsors and contract research


 since the mid-1990s, so most kinks have been worked out, Mooney says. Consequently,    is erroneous, it can make a trial invalid, says       post-trial study report, adds Sharp IRT services    


IRT randomises patients and directs supply There are two key elements to IRT. First, it is a   randomisation, says Suvoda co-founder and   trial arm, and keeps the studies blinded, Kole explains.  the clinical trial supply chain. “Trials need the


30 | Clinical Trial Supply Handbook


       and expiry dates, are then loaded onto the IRT, says Natalie Townsend, vice president,      requirements, Kole adds.   can be sent. IRT allows supply traceability   accountability in terms of what inventory is   Louis Minham. “Essentially, IRT systems automate what


otherwise would have been based on paper or 


IRT forecasting critical   to the site is a critical step. There are predictive and non-predictive    site needs for future patient visits, he explains. The patient has a schedule, and the IRT makes sure there is supply for those visits, he adds. To enable a non-predictive method, sites


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56